Teva agrees to $35 million settlement over delayed generic asthma inhalers
read at Endpoints ↗RegulatoryNegative
A Massachusetts federal judge approved a settlement involving Teva Pharmaceuticals and several healthcare funds.
The agreement sets the payment at $35 million to resolve the dispute.
The funds allege that Teva postponed the launch of generic versions of its asthma inhalers, which they say led to higher drug prices.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Judge signs off on Teva's $35M settlement over delayed inhaler generics”
read at Endpoints ↗82 words · retrieved 2h ago
comments(0)
5-min edit window · permanent after that